BioPharma Pharma Research
HanAll, Daewoong, and NurrOn Launch Phase 1 Study for HL192
HanAll Biopharma and Daewoong Pharmaceutical marked a pivotal step forward in the development of HL192 (ATH-399A) for the potential treatment of Parkinso...
October 13, 2023 | News
GE HealthCare Expands Human Subject Research with Stanford Medicine Using Photon Counting CTi Technology
Unique from current CT technology, GE HealthCare’s proprietary photon counting CT design is engineered to leverage Deep Silicon detectors with the ...
October 10, 2023 | News
Kexing Biopharm Hosts High-end Forum for China-MENA & South Asia Pharma Cooperation in Emerging Markets
MENA and South Asia are recognized as pivotal regions for Kexing Biopharm's overseas business expansion. The event brought together industry experts and he...
October 10, 2023 | News
Everest Medicines' Partner Calliditas Shares NefIgArd Phase 3 Trial Data at ISIN Tokyo 2023
"The positive findings from biomarker and patient subgroup analyses from the Phase 3 NefIgArd study highlights that Nefecon® treatment results in ...
October 05, 2023 | News
ZEISS and Boehringer Ingelheim Collaborate on Early Eye Disease Detection to Prevent Vision Loss.
The partnership brings together their leading expertise in ophthalmological technology, data analytics, algorithms and the development of first-in-class tr...
October 03, 2023 | News
OBiO Launches GMP Facility Intelli-M for Rapid Delivery of Innovative Therapies
The launch of the new base in Shanghai will enhance OBiO's production and service capabilities in both China and the United States...
September 28, 2023 | News
Centre for Ion Beam Applications at NUS designated as IAEA's first Collaborating Centre in Singapore
The Centre for Ion Beam Applications (CIBA), a multidisciplinary research centre at the National University of Singapore (NUS), h...
September 21, 2023 | News
China's NMPA Recommends Priority Review for Cefepime-Taniborbactam in UTI Treatment
"Currently, the clinical challenges from multi-drug resistant infections are severe. The recommendation of priority review by CDE for cefepime-taniborbacta...
September 20, 2023 | News
Australia Launches National Study on Back and Neck Pain Risk Factors
The University of Adelaide's Experts Lead Landmark Australian Study on Back and Neck Pain A team of experts from the University of Adelaide is spearheadin...
September 18, 2023 | News
MGI Collaborates with National Cancer Centre Singapore for Asian Cancer Genomic Profiling
"We are excited to work with NCCS to uncover the unique molecular genomic composition of cancers prevalent in Asia by providing our DNBSEQ-G400 s...
September 18, 2023 | News
Samsung Biologics Expands Agreement with Bristol Myers Squibb to Manufacture Cancer Drug
Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the s...
September 18, 2023 | News
BioRay's Zuberitamab (Anruixi®) First Domestic Anti-CD20 Antibody Approved in China
In preclinical studies, Anruixi® showed stronger antibody-dependent cell-mediated cytotoxicity (ADCC), a larger volume of distribution at steady state,...
September 14, 2023 | News
Takara Bio Europe Launches Enzymes for mRNA Vaccine R&D
Takara Bio Europe (TBE) announced the launch of new High Quality (HQ) grade mRNA production enzymes "T7 RNA polymerase, HQ" and "Pyrophosphatas...
September 13, 2023 | News
Waters Introduces Simplified Solutions for Biologic Drug Analysis
Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccord™ LC-MS system and...
September 13, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
